FibroGen (FGEN) Misses Q4 EPS by 79c
Tweet
Share
E-mail
Get Alerts FGEN Hot Sheet
Join SI Premium – FREE
FibroGen (NASDAQ: FGEN) reported Q4 EPS of ($1.45), $0.79 worse than the analyst estimate of ($0.66). Revenue for the quarter came in at $16.5 million versus the consensus estimate of $47.65 million.
For earnings history and earnings-related data on FibroGen (FGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Okta upgraded as AI security opportunity boosts outlook
- Humacyte, Inc. (HUMA) Misses Q2 EPS by 7c
- Performance Food Group (PFGC) Misses Q4 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
